Gout can be secondary to kidney disease, certain medications, blood cancers, organ transplant drugs, thyroid disorders, lead exposure, genetic enzyme deficiencies, and skin conditions like psoriasis. In all these cases, something other than your body’s baseline metabolism is driving uric acid levels high enough to trigger crystal formation in your joints. Understanding the underlying cause matters because treating secondary gout often means addressing that root problem, not just managing flares.
Chronic Kidney Disease
Your kidneys are responsible for filtering uric acid out of your blood. When kidney function declines, uric acid excretion drops significantly. In studies of gout secondary to chronic kidney disease, daily uric acid production stayed normal, but the kidneys could only clear about 35% of it. The rest had to be eliminated through the gut and other pathways, which couldn’t fully compensate. The result is a steady buildup of uric acid in the blood.
This is one of the most common causes of secondary gout. Any condition that damages the kidneys over time, including diabetes, longstanding high blood pressure, or polycystic kidney disease, can impair urate clearance enough to trigger gout. If you develop gout and blood tests show signs of reduced kidney function, your doctor will likely investigate whether kidney disease is the driving factor.
Diuretics and Other Medications
Diuretics (water pills) are among the most well-known medication triggers for gout. Both thiazide diuretics, commonly prescribed for high blood pressure, and loop diuretics, used for heart failure and fluid retention, raise uric acid levels. They do this by affecting transport proteins in the kidney’s filtering tubes, increasing the reabsorption of both sodium and uric acid back into the bloodstream instead of letting them pass into urine. This effect goes beyond whatever impact high blood pressure itself has on uric acid levels.
Low-dose aspirin is another common culprit that often surprises people. Aspirin has a dual effect on uric acid depending on the dose. At high doses (above 3 grams per day), it actually helps the body excrete uric acid. But at low doses, the kind millions of people take daily for heart protection, it does the opposite. Even 75 milligrams per day caused a 15% decrease in uric acid excretion in one study of elderly patients, with a measurable rise in blood uric acid levels within a single week.
Organ Transplant Medications
People who receive organ transplants frequently develop gout because of the immunosuppressive drugs they need to prevent rejection. Cyclosporine is the best-established offender. It raises uric acid through a double mechanism: it increases uric acid reabsorption in the kidney and constricts blood vessels feeding the kidney’s filtering units, reducing the overall filtration rate. Tacrolimus, a newer alternative, also reduces uric acid excretion but through a simpler mechanism, which may explain why gout cases linked to it are less common.
Among liver transplant patients specifically, elevated uric acid levels occur in 14% to 47% of recipients, largely because of the accompanying decline in kidney function that these drugs cause. For transplant patients, managing gout becomes a balancing act since the medications causing the problem can’t simply be stopped.
Blood Cancers and High Cell Turnover
Conditions that cause rapid production and destruction of blood cells generate large amounts of uric acid as a byproduct. Uric acid is the end product of breaking down purines, which are building blocks of DNA. When cells are being created and destroyed at abnormal rates, purine breakdown accelerates dramatically.
Myeloproliferative neoplasms, a group of blood cancers that includes polycythemia vera, essential thrombocythemia, and myelofibrosis, are classic triggers. The heightened proliferation and turnover of blood-forming cells in these conditions directly elevates uric acid. Leukemia and lymphoma can do the same, and chemotherapy can make things worse by killing off large numbers of cancer cells all at once, flooding the body with purines. This is why patients undergoing cancer treatment are sometimes given medications to prevent a dangerous uric acid spike.
Psoriasis
Severe psoriasis can raise uric acid levels through a mechanism similar to blood cancers, just involving the skin instead of bone marrow. Psoriasis causes abnormally rapid growth of skin cells called keratinocytes. As these cells proliferate and turn over at accelerated rates, the breakdown of their DNA releases purines that get converted into uric acid. The more extensive the psoriasis, the greater the potential effect on uric acid levels. This link between psoriasis and gout is sometimes overlooked because the two conditions seem unrelated on the surface, but the connection is the shared biology of cell turnover and purine metabolism.
Thyroid Disorders
Hypothyroidism, an underactive thyroid, increases gout risk by slowing kidney filtration. Thyroid hormones directly influence how efficiently your kidneys work. When thyroid hormone levels drop, the glomerular filtration rate decreases, meaning less uric acid gets filtered out. Population-level research has confirmed that patients with hypothyroidism face a higher risk of developing gout compared to people with normal thyroid function.
Interestingly, hyperthyroidism (overactive thyroid) also carries a slightly elevated gout risk despite increasing filtration rate. This suggests that thyroid dysfunction affects uric acid handling through additional pathways beyond simple filtration, possibly through metabolic or cardiovascular effects on the kidneys that standard tests don’t capture.
Lead Exposure
Chronic lead exposure causes a specific form called saturnine gout, recognized for centuries. Lead damages the kidney’s tubules directly, causing scarring and increasing the reabsorption of uric acid while decreasing its secretion. Workers with lead exposure show significantly higher uric acid levels than unexposed controls, and the longer the exposure, the worse kidney function becomes.
Saturnine gout looks different from typical gout in several ways. It affects men and women equally, while primary gout heavily favors men. It tends to involve the knee rather than the classic big toe. Acute flares are less frequent but the condition is more likely to be accompanied by kidney disease, anemia, and protein in the urine. Occupational lead exposure has declined in many countries, but it still occurs in industries like battery manufacturing, smelting, and construction involving old lead paint.
Genetic Enzyme Deficiencies
Some people develop secondary gout because of inherited metabolic disorders. The most dramatic example is Lesch-Nyhan syndrome, caused by a severe deficiency of an enzyme in the purine recycling pathway. Normally, this enzyme recycles the purine building blocks hypoxanthine and guanine back into usable molecules. Without it, those purines pile up and get converted into uric acid instead. The deficiency also ramps up new purine production through a separate pathway, compounding the problem.
When enzyme activity drops below 1.5% of normal, the full syndrome develops, which includes not only gout and kidney stones but also neurological problems and self-injurious behavior. Partial deficiencies of the same enzyme cause a milder condition with gout and kidney stones but without the neurological features. These genetic causes are rare, but they’re important to consider when gout appears unusually early in life or in someone without the typical risk factors.
How Secondary Gout Differs in Practice
The joint pain and swelling of secondary gout feel identical to primary gout. Uric acid crystals don’t care why they formed. The difference is in the strategy: treating flares alone won’t solve the problem if the underlying cause keeps pushing uric acid levels up. Someone whose gout is driven by a diuretic may improve with a medication switch. A person with untreated hypothyroidism may see their uric acid normalize with thyroid hormone replacement. A transplant patient may need careful dose adjustments to their immunosuppressive regimen.
If you’ve been diagnosed with gout and also have any of the conditions above, or take medications known to raise uric acid, it’s worth discussing whether your gout might be secondary. Identifying the root cause can change both the treatment approach and the long-term outlook.